PF-AtlasКлинические испытания › NCT05318599

Deep Learning Diagnostic and Risk-stratification for IPF and COPD

Lung auscultation · Не указано

ID реестра
NCT05318599
Фаза
Не указано
Статус
Неизвестно
Препарат / вмешательство
Lung auscultation
Спонсор
Pediatric Clinical Research Platform
Начало
2023-04-01
Набор участников
160
Центры
1

Об исследовании

Idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP), and chronic obstructive pulmonary disease (COPD) are severe, progressive, irreversibly incapacitating pulmonary disorders with modest response to therapeutic interventions and poor prognosis. Prompt and accurate diagnosis is important to enable patients to receive appropriate care at the earliest possible stage to delay disease progression and prolong survival. Artificial intelligence (AI)-assisted digital lung auscultation could constitute an alternative to conventional subjective operator-related auscultation to accurately and earlier diagnose these diseases. Moreover, lung ultrasound (LUS), a relevant gold standard for lung pathology, could also benefit from automation by deep learning.

Открыть NCT05318599 на ClinicalTrials.gov →

Связанные материалы

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT05318599 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.